Cartwheel cells constitute a prominent group of neurons within the dorsal cochlear nucleus (DCN), where they outnumber other inhibitory interneurons. Positioned superficially in the pyramidal layer of the DCN, these cells receive input from the parallel fibers of the granule cell layer through their dendrites. Although their axons are confined to the dorsal cochlear nucleus, they form synaptic connections with other cartwheel cells and pyramidal cells within the DCN, releasing neurotransmitters like GABA and glycine onto their targets. Characterized by soma placement, dendritic structure, and neurotransmitter release patterns, cartwheel cells exhibit spiking patterns reminiscent of Purkinje cells in the cerebellum. The similarities extend to features such as complex spike bursts and simple spikes. Morphologically, cartwheel cells possess myelinated axons, a spherical cell shape, and medium-sized cell bodies, accompanied by a high density of spines on their dendrites. The principal targets of cartwheel cells are the large efferent pyramidal neurons located in layer two of the DCN. Research indicates that the modulation of pyramidal cell activity by cartwheel cells plays a pivotal role in shaping the overall output of the superficial layers of the dorsal cochlear nucleus.
Title : AI-integrated high-throughput tissue-chip for space-based biomanufacturing applications
Kunal Mitra, Florida Tech, United States
Title : Stem cell technologies to integrate biodesign related tissue engineering within the frame of cell based regenerative medicine: towards the preventive therapeutic and rehabilitative resources and benefits
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : In vitro evaluation of lyophilized Dedifferentiated Fat cells (DFAT) impregnated artificial dermis
Kazutaka Soejima, Nihon University, School of Medicine, Japan
Title :
Nagy Habib, Imperial College London, United Kingdom
Title :
Alexander Seifalian, Nanotechnology & Regenerative Medicine Commercialisation Centre, United Kingdom
Title : The regenerative medicine of the future
Marco Polettini, DVM, Italy